Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance

NCT ID: NCT01798043

Last Updated: 2020-07-24

Basic Information

• Recruitment Status: TERMINATED
• Clinical Phase: NA
• Total Enrollment: 29 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2013-01-31
• Study Completion Date: 2016-01-31

Brief Summary

The study aims to use cardiac MRI scans and analysis techniques to evaluate differences in cardiac function after 12 months of pacing in patients with pacing leads placed in different positions within the right ventricle (apically or septally).

Detailed Description

Prolonged pacing from the right ventricular (RV) Apex has been shown to be associated with progressive left ventricular (LV) dysfunction. This has led to an interest in alternative right ventricular pacing sites. Only very few studies investigated the effect of alternative right ventricular pacing sites using three dimensional imaging. Using cardiac MRI volumetric left- and right ventricular analysis and three-dimensional reconstruction is more accurate compared to trans-thoracic echocardiogram. St. Jude Medical has developed a MRI conditional pacemaker system enabling for the first time to investigate alternative pacing sites using cardiac MRI.

Patients already implanted with an MRI conditional pacemaker system from St. Jude Medical will be enrolled in that study and subdivided into 4 groups (right ventricular pacing lead positioned apically or septally subdivided in patients paced for <50% of time or 50% or more). All patients will undergo cardiac MRI at enrollment and again 12 months later. Patients paced <50% of the time will undergo cardiac MRI with and without pacemaker stimulation at both visits.

Conditions

Heart Block; Sick Sinus Syndrome; Atrioventricular Block; Ventricular Dysfunction

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: DIAGNOSTIC
• Blinding Strategy: NONE

Study Groups

Septal RV lead with >50% pacing (B1)

Cardiac MRI with pacemaker stimulation

Group Type: EXPERIMENTAL

Cardiac MRI with pacemaker stimulation

Intervention Type: OTHER

Patient is undergoing a Cardiac MRI at enrollment and 12 months later

Septal RV lead with <50% pacing (B2)

Cardiac MRI with and without pacemaker stimulation

Group Type: EXPERIMENTAL

Cardiac MRI with and without pacemaker stimulation

Intervention Type: OTHER

Patient is undergoing a Cardiac MRI at enrollment and 12 months later

Apical RV lead with >50% pacing (A1)

Cardiac MRI with pacemaker stimulation

Group Type: EXPERIMENTAL

Cardiac MRI with pacemaker stimulation

Intervention Type: OTHER

Patient is undergoing a Cardiac MRI at enrollment and 12 months later

Apical RV lead with <50% pacing (A2)

Cardiac MRI with and without pacemaker stimulation

Group Type: EXPERIMENTAL

Cardiac MRI with and without pacemaker stimulation

Intervention Type: OTHER

Patient is undergoing a Cardiac MRI at enrollment and 12 months later

Interventions

Cardiac MRI with pacemaker stimulation

Patient is undergoing a Cardiac MRI at enrollment and 12 months later

Intervention Type: OTHER

Cardiac MRI with and without pacemaker stimulation

Patient is undergoing a Cardiac MRI at enrollment and 12 months later

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Have been implanted with an Accent MRI pacemaker and Tendril MRI leads.
• Have an RV lead implanted apically (group A) or septally (Group B)
• Are RV paced for <50% of the time (groups A2 and B2)
• Are RV paced for > 50% of the time (Groups A1 and B1)
• Are ≥ 18 years of age.
• Are able to provide written informed consent.
• Are willing and able to comply with the prescribed follow-up tests and schedule of evaluations.

Exclusion Criteria

• Have permanent atrial fibrillation with preserved intrinsic conduction
• Have a non-MRI compatible device or material implant (e.g., intracranial aneurysm clip, non-MRI compatible devices or material, metals or alloys, etc.).
• Have a lead extender, plug or adaptor.
• Do not have an RV lead implanted apically or septally.
• Are eligible for groups A1 or B1 but appropriate group already has 20 patients enrolled.
• Are eligible for groups A2 or B2 but appropriate group already has 5 patients enrolled
• Are currently participating in another device or drug investigation which includes an active treatment arm.
• Are pregnant or planning to become pregnant during the duration of the study.
• Have a life expectancy of less than 12 months from Screening due to any life-threatening condition.
• Are contraindicated for an MRI scan due to any other reason.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Abbott Medical Devices

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Rainer Zbinden, MD

Role: PRINCIPAL_INVESTIGATOR

Triemli Hospital

Locations

Stadtspital Triemli

Zurich, , Switzerland

Countries

Switzerland

Other Identifiers

CR-12-048-CH-LV

Identifier Type: -

Identifier Source: org_study_id